Erratum to: Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: The TEACHH model: Life Expectancy in Metastatic Cancer (Cancer, (2014), 120, 1, (134-141), 10.1002/cncr.28408);Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: The TEACHH model

Cancer

Volumn 120, Issue 1, 2014, Pages 134-141

  Krishnan, Monica S ^a   Epstein Peterson, Zachary ^b   Chen, Yu Hui ^c,d   Tseng, Yolanda D ^a   Wright, Alexi A ^b,d   Temel, Jennifer S ^a   Catalano, Paul ^c,e   Balboni, Tracy A ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

life expectancy; metastatic; model; palliative; prediction

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; LIVER METASTASIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK FACTOR;

LIFE EXPECTANCY; METASTATIC; MODEL; PALLIATIVE; PREDICTION;

FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM METASTASIS; NEOPLASMS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84890794017     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.32000     Document Type: Erratum

References (38)

1. Gripp S, Mjartan S, Boelke E, et al. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Cancer. 2010; 116: 3251-3256.
2. Guadagnolo BA, Liao KP, Elting L, et al. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol. 2013; 31: 80-87.
3. Chow E, Harth T, Hruby G, et al. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol). 2001; 13: 209-218. (Pubitemid 32600214)
4. Christakis NA, Lamont EB,. Extent and determinants of error in physicians' prognoses in terminally ill patients: prospective cohort study. West J Med. 2000; 172: 310-313. (Pubitemid 30333909)
5. Mackillop WJ, Quirt CF,. Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol. 1997; 50: 21-29. (Pubitemid 27089204)
6. Peppercorn JM, Smith TJ, Helft PR, et al; American Society of Clinical Oncology. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011; 29: 755-760.
7. Centers for Medicare and Medicaid Services. Medicare Hospice Benefits. Baltimore, MD: Centers for Medicare and Medicaid Services, US Department of Health and Human Services; 2010.
8. National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Palliative Care. Fort Washington, PA: National Comprehensive Cancer Network; 2011.
9. Dahlin C, ed. National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative Care. 3rd ed. Pittsburgh, PA: National Consensus Project; 2013.
10. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005; 30: 2186-2191. (Pubitemid 41429199)
11. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001; 26: 298-306. (Pubitemid 32144129)
12. Rades D, Panzner A, Rudat V, et al. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis. Strahlenther Onkol. 2011; 187: 729-735.
13. Chow E, Abdolell M, Panzarella T, et al. Predictive model for survival in patients with advanced cancer. J Clin Oncol. 2008; 26: 5863-5869.
14. Chow E, James JL, Hartsell W, et al. Validation of a predictive model for survival in patients with advanced cancer: secondary analysis of RTOG 9714. World J Oncol. 2011; 2: 181-190.
15. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745-751. (Pubitemid 27181303)
16. Martin L, Watanabe S, Fainsinger R, et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol. 2010; 28: 4376-4383.
17. Gwilliam B, Keeley V, Todd C, et al. Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study. BMJ. 2011; 343: d4920.
18. Chiang JK, Cheng YH, Koo M, et al. A computer-assisted model for predicting probability of dying within 7 days of hospice admission in patients with terminal cancer. Jpn J Clin Oncol. 2010; 40: 449-455.
19. Feliu J, Jimenez-Gordo AM, Madero R, et al. Development and validation of a prognostic nomogram for terminally ill cancer patients. J Natl Cancer Inst. 2011; 103: 1613-1620.
20. Lingjun Z, Jing C, Jian L, et al. Prediction of survival time in advanced cancer: a prognostic scale for Chinese patients. J Pain Symptom Manage. 2009; 38: 578-586.
21. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999; 17: 231-239. (Pubitemid 29159965)
22. Suh SY, Choi YS, Shim JY, et al. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer. 2010; 18: 151-157.
23. Tredan O, Ray-Coquard I, Chvetzoff G, et al. Validation of prognostic scores for survival in cancer patients beyond first-line therapy. BMC Cancer. 2011; 11: 95.
24. Chan EY, Wu HY, Chan YH,. Revisiting the Palliative Performance Scale: change in scores during disease trajectory predicts survival. Palliat Med. 2013; 27: 367-374.
25. Sanchez-Munoz A, Perez-Ruiz E, Saez MI, et al. Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status. Clin Transl Oncol. 2011; 13: 426-429.
26. Collett D,. Modelling Survival Data in Medical Research. London: Chapman & Hall; 1994.
27. Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ,. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011; 30: 1105-1117.
28. Coia LR, Hanks GE, Martz K, et al. Practice patterns of palliative care for the United States 1984-1985. Int J Radiat Oncol Biol Phys. 1988; 14: 1261-1269.
29. Huang J, Zhou S, Groome P, et al. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001; 19: 137-144. (Pubitemid 32063490)
30. Janjan NA,. An emerging respect for palliative care in radiation oncology. J Palliat Med. 1998; 1: 83-88.
31. McCloskey SA, Tao ML, Rose CM, et al. National survey of perspectives of palliative radiation therapy: role, barriers, and needs. Cancer J. 2007; 13: 130-137.
32. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005; 366: 643-648. (Pubitemid 41176016)
33. Expert Panel on Radiation Oncology-Brain Metastases, Videtic GM, Gaspar LE, Aref AM, et al. American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys. 2009; 75: 961-965.
34. Howell DD, James JL, Hartsell WF, et al. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer. 2013; 119: 888-896.
35. Rades D, Panzner A, Dziggel L, Haatanen T, Lohynska R, Schild SE,. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer. 2012; 118: 3852-3859.
36. Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D,. Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer. 2012; 12: 261.
37. Rades D, Douglas S, Huttenlocher S, et al. Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer. Strahlenther Onkol. 2012; 188: 1114-1118.
38. Buccheri G, Ferrigno D, Tamburini M,. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996; 32A: 1135-1141.